Common use of Subsequent Activities Clause in Contracts

Subsequent Activities. RayzeBio shall, at its discretion, conduct pre-clinical and toxicology or pre-IND enabling studies with respect to one or more Selected Conjugates to one or more Collaboration Targets. RayzeBio shall communicate study results to PeptiDream. Upon RayzeBio’s reasonable request and at RayzeBio’s sole expense, PeptiDream will use Commercially Reasonable Efforts to make derivatives of Selected Conjugates to modify molecular characteristics and behavior in vivo, and any resulting conjugate will be deemed a Selected Conjugate. For clarity, RayzeBio shall at all times have the right to make Derivatives, itself or through an Affiliate or Subcontractor, including by derivatizing Hits and subsequently conjugating them to chelator agents, and shall not be obligated to request that PeptiDream conduct any further modification or characterization of Hits or Selected Conjugates.